Novartis (Ophthalmology Division) Overview

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • M&A

  • Financing Rounds
  • 1

Novartis (Ophthalmology Division) General Information

Description

Manufacturer of pharmaceutical products based in Switzerland. The company manufactures pharmaceutical products across multiple therapeutic areas, including cardiovascular, renal and metabolic diseases, immunology, neuroscience, and oncology.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Corporate Office
  • Switzerland
Primary Industry
Pharmaceuticals
Acquirer
Santen Pharmaceutical
Vertical(s)
Manufacturing, Life Sciences, Oncology
Corporate Office
  • Switzerland

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Novartis (Ophthalmology Division) Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Novartis (Ophthalmology Division)‘s full profile, request access.

Request a free trial

Novartis (Ophthalmology Division) Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Novartis (Ophthalmology Division)‘s full profile, request access.

Request a free trial

Novartis (Ophthalmology Division) FAQs

  • Where is Novartis (Ophthalmology Division) headquartered?

    Novartis (Ophthalmology Division) is headquartered in Switzerland.

  • What industry is Novartis (Ophthalmology Division) in?

    Novartis (Ophthalmology Division)’s primary industry is Pharmaceuticals.

  • Is Novartis (Ophthalmology Division) a private or public company?

    Novartis (Ophthalmology Division) is a Private company.

  • What is Novartis (Ophthalmology Division)’s current revenue?

    The current revenue for Novartis (Ophthalmology Division) is .

  • Who are Novartis (Ophthalmology Division)’s investors?

    Novartis has invested in Novartis (Ophthalmology Division).

  • When was Novartis (Ophthalmology Division) acquired?

    Novartis (Ophthalmology Division) was acquired on 20-Oct-2025.

  • Who acquired Novartis (Ophthalmology Division)?

    Novartis (Ophthalmology Division) was acquired by Santen Pharmaceutical.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process